ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Synthesis

Re: Conquering KRas

June 13, 2016 | APPEARED IN VOLUME 94, ISSUE 24

[+]Enlarge
Credit: Yang H. Ku/C&EN/Shutterstock
Credit: Yang H. Ku/C&EN/Shutterstock

Lisa Jarvis’s investigation into efforts to develop drugs capable of blocking a mutated form of the protein KRas found in cancer (C&EN, June 6, page 28) intrigued online readers.
▸ cenm.ag/krasdrugs

[The story is] a great piece—the type that makes @cenmag important reading.

John LaMattina (@John_LaMattina) via Twitter

Very nice article. I was writing a grant application on KRas today when I saw the @cenmag cover.

Ho Leung Ng (@HawaiiSci) via Twitter

A drug to shut down KRas. Kinda like catching fish with your bare hands—in the desert. Good luck!

Andreas Harsch (@AndreasHarsch) via Twitter

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment